Get the Stockscreener App
1.66
4.05%
-0.07
After Hours:
1.68
0.02
+1.20%
Seer Inc stock is traded at $1.66, with a volume of 438.86K.
It is down -4.05% in the last 24 hours and down -11.23% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.73
Open:
$1.72
24h Volume:
438.86K
Relative Volume:
1.40
Market Cap:
$91.27M
Revenue:
$15.04M
Net Income/Loss:
$-70.49M
P/E Ratio:
-1.334
EPS:
-1.2444
Net Cash Flow:
$-49.88M
1W Performance:
-4.60%
1M Performance:
-11.23%
6M Performance:
-9.78%
1Y Performance:
-19.42%
1-Day Range:
$1.66
$1.7573
1-Week Range:
$1.66
$1.78
52-Week Range:
$1.65
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.66 | 91.27M | 15.04M | -70.49M | -49.88M | -1.2444 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer Inc | DFAN14A: Definitive additional proxy soliciting materials filed by non-management - Moomoo
Seer, Inc. Class A Actuals & Estimates (NASDAQ:SEER) - TradingView
Seer, Inc. Class A Actuals & Estimates (BOATS:SEER) - TradingView
Price to book forward of Seer, Inc. – NASDAQ:SEER - TradingView
Enterprise value to revenue forward of Seer, Inc. – NASDAQ:SEER - TradingView
SEER Forecast — Price Target — Prediction for 2027 - TradingView
Seer Inc (SEER) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
The Radoff-JEC Group Urges Seer Stockholders to Vote for Boardroom Change - marketscreener.com
Radoff-JEC seeks Seer board seats (NASDAQ: SEER) in proxy contest - Stock Titan
The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today - Investing News Network
Seer (SEER) Faces Criticism Over Value Destruction and Leadershi - GuruFocus
Seer and Korea University test AI plasma data for 10 cancers - Stock Titan
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening - Investing News Network
Seer presents preliminary data on AI-driven cancer screening By Investing.com - Investing.com South Africa
Seer presents preliminary data on AI-driven cancer screening - Investing.com
Seer Inc (SEER) Institutional Confidence - TradingKey
Seer Inc (SEER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Seer Inc (SEER) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Seer Inc (SEER) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Seer Inc (SEER) Valuation: PE, PB & Fair Value Analysis - TradingKey
Seer Inc (SEER) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Seer Inc (SEER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Seer Inc (SEER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Seer Inc (SEER) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Seer Inc. (SEER) Holds Steady at $1.71 as Stock Consolidates Near Key SupportChange of Character - newsline.com
[DFAN14A] Seer, Inc. SEC Filing - Stock Titan
Bradley L. Radoff Files a Definitive Proxy Statement and Urges the Seer, Inc.'s Board - marketscreener.com
Seer (SEER) Faces Calls for Change Amid Significant Share Price Decline - GuruFocus
The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO - GuruFocus
The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction - Investing News Network
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction - Business Wire
Seer urges stockholders to vote for board nominees amid activist challenge - Investing.com Nigeria
Seer urges stockholders to vote for board nominees amid activist challenge By Investing.com - Investing.com South Africa
Seer, Inc. Urges Stockholders to Support Board Nominees Ahead of Upcoming Annual Meeting - Quiver Quantitative
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign - The Manila Times
Seer Inc. (SEER) Q1 2026 Earnings: Narrow EPS Beat Amidst Uncertain Revenue OutlookRevenue Growth Report - newsline.com
Seer (SEER) price target increased by 33.33% to 4.08 - MSN
Seer, Inc Provides Information to the Shareholders - marketscreener.com
Bradley L. Radoff Files a Definitive Proxy Statement and Sent a Letter to Shareholders - marketscreener.com
Radoff-JEC Group seeks seats at Seer (NASDAQ: SEER) with 4.28M shares - Stock Titan
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders - The Manila Times
Seer, Inc. Urges Stockholders to Support Board Nominees Amid Proxy Contest with Activist Investors - Quiver Quantitative
Seer Solicits Proxies from Shareholders - marketscreener.com
Tranche Update on Seer, Inc.'s Equity Buyback Plan announced on May 8, 2024. - marketscreener.com
Seer Q1 earnings call highlights - MSN
Seer Inc. (SEER) Shares Decline Amidst Market Headwinds, Testing Key Support LevelsCall Wall - The Legal Advocate
Seer Files ITC Complaint Against Nanomics - Investing News Network
Seer Inc. (SEER) Slides 1.5% as Selling Pressure Tests Key Support Near $1.80Volatility Breakout Picks - newsline.com
Seer Inc. (SEER) Q1 2026 Earnings: Narrow EPS Beat Highlights Cost DisciplineEPS Revision Trend - The Legal Advocate
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Horn David R. | PRESIDENT & CFO |
Feb 18 '26 |
Sale |
1.99 |
7,743 |
15,447 |
501,262 |
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):